To determine if ICAM1 is a valid target in TNBC and metastasis, we further examined the clinical relevance of ICAM1 expression to patient outcomes by analyzing two independent breast cancer patient cohorts, GSE2505540 and GSE145641. This evidence concerns the gene ICAM1 and breast cancer.